COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI BUBU BHBH BLBL CICI HC QHC Q NZNZ COCO More..
00.250.50.7511.251.51.752+Alizadeh (SB RCT)73%0.27 [0.07-1.05]no recov.2/149/17Improvement, RR [CI]TreatmentControlTau​2 = 0.00; I​2 = 0.0%Early treatment73%0.27 [0.07-1.05]2/149/1773% improvementRamlall87%0.13 [0.08-0.22]death196 (n)752 (n)Improvement, RR [CI]TreatmentControlDarban (RCT)33%0.67 [0.14-3.17]progression2/103/10CT​1Farnoosh (DB RCT)81%0.19 [0.01-3.65]ICU0/242/20Tau​2 = 0.49; I​2 = 46.9%Late treatment78%0.22 [0.07-0.68]2/2305/78278% improvementJehi58%0.42 [0.26-0.68]cases16/532802/11,140Improvement, RR [CI]TreatmentControlZhou (PSM)21%0.79 [0.65-0.94]casesTau​2 = 0.17; I​2 = 83.8%PrEP40%0.60 [0.32-1.11]16/532802/11,14040% improvementAll studies64%0.36 [0.16-0.81]20/776816/11,93964% improvement6 melatonin COVID-19 studiesc19melatonin.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.71; I​2 = 89.9%; Z = 2.48Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Ramlall87%0.13 [0.08-0.22]196 (n)752 (n)Improvement, RR [CI]TreatmentControlTau​2 = 0.00; I​2 = 0.0%Late treatment87%0.13 [0.08-0.22]0/1960/75287% improvementAll studies87%0.13 [0.08-0.22]0/1960/75287% improvement1 melatonin COVID-19 mortality resultc19melatonin.com Aug 29, 2021Tau​2 = 0.00; I​2 = 0.0%; Z = 7.55Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Darban (RCT)6%0.94 [0.84-1.06]10 (n)10 (n)CT​1Improvement, RR [CI]TreatmentControlFarnoosh (DB RCT)81%0.19 [0.01-3.65]0/242/20Tau​2 = 0.16; I​2 = 12.2%Late treatment15%0.85 [0.39-1.84]0/342/3015% improvementAll studies15%0.85 [0.39-1.84]0/342/3015% improvement2 melatonin COVID-19 ICU resultsc19melatonin.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.16; I​2 = 12.2%; Z = 0.42Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Ramlall87%0.13 [0.08-0.22]death196 (n)752 (n)Improvement, RR [CI]TreatmentControlDarban (RCT)33%0.67 [0.14-3.17]progression2/103/10CT​1Farnoosh (DB RCT)81%0.19 [0.01-3.65]ICU0/242/20Tau​2 = 0.49; I​2 = 46.9%Late treatment78%0.22 [0.07-0.68]2/2305/78278% improvementAll studies78%0.22 [0.07-0.68]2/2305/78278% improvement3 melatonin COVID-19 serious outcomesc19melatonin.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.49; I​2 = 46.9%; Z = 2.63Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Jehi58%0.42 [0.26-0.68]16/532802/11,140Improvement, RR [CI]TreatmentControlZhou (PSM)21%0.79 [0.65-0.94]Tau​2 = 0.17; I​2 = 83.8%PrEP40%0.60 [0.32-1.11]16/532802/11,14040% improvementAll studies40%0.60 [0.32-1.11]16/532802/11,14040% improvement2 melatonin COVID-19 case resultsc19melatonin.com Aug 29, 2021Tau​2 = 0.17; I​2 = 83.8%; Z = 1.62Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Alizadeh (SB RCT)73%0.27 [0.07-1.05]no recov.2/149/17Improvement, RR [CI]TreatmentControlTau​2 = 0.00; I​2 = 0.0%Early treatment73%0.27 [0.07-1.05]2/149/1773% improvementDarban (RCT)33%0.67 [0.14-3.17]progression2/103/10CT​1Improvement, RR [CI]TreatmentControlFarnoosh (DB RCT)81%0.19 [0.01-3.65]ICU0/242/20Tau​2 = 0.00; I​2 = 0.0%Late treatment49%0.51 [0.13-2.02]2/345/3049% improvementAll studies63%0.37 [0.14-0.97]4/4814/4763% improvement3 melatonin COVID-19 Randomized Controlled Trialsc19melatonin.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.00; I​2 = 0.0%; Z = 2.02Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Alizadeh (SB RCT)73%0.27 [0.07-1.05]no recov.2/149/17Improvement, RR [CI]TreatmentControlTau​2 = 0.00; I​2 = 0.0%Early treatment73%0.27 [0.07-1.05]2/149/1773% improvementDarban (RCT)33%0.67 [0.14-3.17]progression2/103/10CT​1Improvement, RR [CI]TreatmentControlFarnoosh (DB RCT)81%0.19 [0.01-3.65]ICU0/242/20Tau​2 = 0.00; I​2 = 0.0%Late treatment49%0.51 [0.13-2.02]2/345/3049% improvementJehi58%0.42 [0.26-0.68]cases16/532802/11,140Improvement, RR [CI]TreatmentControlZhou (PSM)21%0.79 [0.65-0.94]casesTau​2 = 0.17; I​2 = 83.8%PrEP40%0.60 [0.32-1.11]16/532802/11,14040% improvementAll studies46%0.54 [0.33-0.90]20/580816/11,18746% improvement5 melatonin COVID-19 peer reviewed trialsc19melatonin.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.14; I​2 = 56.9%; Z = 2.39Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Alizadeh (SB RCT)73%0.27 [0.07-1.05]no recov.2/149/17Improvement, RR [CI]TreatmentControlRamlall87%0.13 [0.08-0.22]death196 (n)752 (n)Darban (RCT)33%0.67 [0.14-3.17]progression2/103/10CT​1Darban (RCT)6%0.94 [0.84-1.06]ICU10 (n)10 (n)CT​1Farnoosh (DB RCT)81%0.19 [0.01-3.65]ICU0/242/20Farnoosh (DB RCT)49%0.51 [0.32-0.81]recov. time24 (n)20 (n)Farnoosh (DB RCT)44%0.56 [0.10-3.00]no disch.2/243/20Farnoosh (DB RCT)43%0.57 [0.35-0.92]no disch.24 (n)20 (n)Jehi58%0.42 [0.26-0.68]cases16/532802/11,140Jehi100%0.00 [0.00-0.05]cases0/18290/2,005Zhou (PSM)21%0.79 [0.65-0.94]casesmelatonin COVID-19 outcomesc19melatonin.com Aug 29, 2021Lower RiskIncreased Risk
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit    
Aspirin
Bamlanivimab
Bromhexine
Budesonide
Casirivimab/i..
Colchicine
Curcumin
Favipiravir
Fluvoxamine
Hydroxychloro..
Iota-carragee..
Ivermectin
Melatonin
Molnupiravir
Nigella Sativa
Nitazoxanide
Povidone-Iod..
Probiotics
Proxalutamide
Quercetin
Remdesivir
Sotrovimab
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home